Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06378957 · ClinicalTrials.gov registry record · Phase 1

Behavioral Pharmacology of Orally Administered THC and D-limonene

A Phase 1 study of THC and Subjective Drug Effects, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 1
Development phase
65
Enrollment target
1
Study location

NCT06378957 is a Phase 1 study of THC and Subjective Drug Effects that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 65 participants, above the 50-participant average among 9 other THC trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06378957, a Phase 1 study of THC and Subjective Drug Effects, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 1
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The current clinical trial will investigate the effects of orally administered d-limonene (limonene), delta-9-tetrahydrocannabinol (THC) and the combination in healthy adult volunteers.

Conditions Studied

THC Subjective Drug Effects D-limonene

Interventions

  • DRUG Placebo
  • DRUG D-Limonene
  • DRUG Delta-9-THC

Study Locations (1)

Maryland

  • Johns Hopkins Behavioral Pharmacology Research Unit - Baltimore

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2025-02-14
Est. Completion 2027-12-31
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06378957

The ClinicalTrials.gov registry entry for NCT06378957 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 50-participant average among 9 other THC trials with a reported enrollment target (30% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with THC appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06378957 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06378957 about?

NCT06378957 is a clinical study titled "Behavioral Pharmacology of Orally Administered THC and D-limonene". The current clinical trial will investigate the effects of orally administered d-limonene (limonene), delta-9-tetrahydrocannabinol (THC) and the combination in healthy adult volunteers.

What is the current status of trial NCT06378957?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2025-02-14. Estimated completion is 2027-12-31.

What conditions does trial NCT06378957 study?

This clinical trial studies the following conditions: THC, Subjective Drug Effects, D-limonene.

What interventions are being tested in trial NCT06378957?

The interventions under investigation include: Placebo (DRUG), D-Limonene (DRUG), Delta-9-THC (DRUG).

Who is sponsoring clinical trial NCT06378957?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06378957 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for THC

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

THC

All registered trials for this condition

Subjective Drug Effects

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.